immune modulation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-10-04 and is reviewed periodically as new material appears.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | 28 residues; not a small-molecule compound |
| Molecular mass | About 3,106 Da | Monoisotopic mass of the unmodified chain |
| N-terminal group | Acetylated serine | Present in both native and synthetic forms |
| Secondary structure | Disulfide-constrained loop | One bridge between two cysteine residues |
| Typical source | Solid-phase synthesis | Early isolates came from bovine thymus extracts |
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.
Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.
Stability depends on temperature, pH, and the number of freeze-thaw events the sample has experienced. Freeze-dried material is commonly held at -20 °C or colder, while reconstituted liquid is kept cold and used within a short window. Extreme pH and prolonged light exposure can promote deamidation, oxidation, or aggregation, particularly at asparagine and methionine positions. Adsorption to container walls can lower the measured concentration of a dilute solution even when the peptide molecules themselves remain intact.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
== Detection in biological specimens == The presence of melamine in urine specimens from children who consumed adulterated milk products has been determined by liquid chromatography-mass spectrometry.
== Immune responses of the cornea == Innate immune responses defend against pathogens and toxins in a non-discriminatory manner. They provide an inherent barrier against corneal infection while also serving as a primary mode of defense that is present from birth. For instance, the orbit and the eyelid can guard against both traumatic events and exterior debris that may contain microorganisms. Other components of the ocular innate immune system include tears, epithelial cells, keratocytes, corneal nerves, the complement system, and interferons. Acquired immune responses are much more pathogen-specific than their innate immune counterparts. These pathways are cell-mediated and are understood to be controlled in part by Langerhans cells in the cornea. These Langerhans cells are antigen-presenting cells, which pick up pieces of invading pathogens and use them to elicit an immune response. Cell-mediated immune responses are much slower acting but more efficient, but can cause damage to surrounding tissue, resulting in damage to the vision.
=== No development reported === Adapalene/minocycline (FCD-105) – combination of adapalene (retinoid) and minocycline (tetracycline antibiotic) Auriclosene (AgaDerm; AgaNase; AL-46383A; CD-07223; DCDMT; NVC-422) – aganocide compound and antimicrobial Bermekimab (CA-18C3; CV-18C3; Hutruo; JNJ-77474462; MAB-p1; RA-18C3; T2-18C3; Xilonix) – monoclonal antibody against interleukin-1α BOS-356 (GSK-3008356) – diacylglycerol O-acyltransferase inhibitor Brilacidin (PMX-30063) – host defense protein (HDP) mimetic antibiotic Carbamide peroxide topical (E-0301) – disinfectant and bleaching agent CJM-112 – IL17A and IL17F inhibitor Clindamycin/tretinoin – combination of clindamycin (lincosamide antibiotic) and tretinoin (retinoid) Clindamycin/tretinoin – combination of clindamycin (lincosamide antibiotic) and tretinoin (retinoid) DMT-200 (DMT-210; DMT-220; SIG-990) – isoprenylcysteine analogue and various actions Estradiol valerate/dienogest (Climodien; Climodiène; Klimodien; Lafamme) – combination of estradiol valerate (estrogen) and dienogest (progestogen) Ethinylestradiol/chlormadinone acetate (Balianca; Belara; GRT4248) – combination of ethinylestradiol (estrogen) and chlormadinone acetate (progestogen) and a combined oral contraceptive Ethinylestradiol/drospirenone (Petibelle; SH-470; Yasmin; ZK-30595) – combination of ethinylestradiol (estrogen) and drospirenone (progestogen) GSK-1940029 – stearoyl-CoA desaturase inhibitor GT-20029 (AR-PROTAC) – androgen receptor degradation enhancer IP10-C8 – CD13 antigen inhibitor and dipeptidyl peptidase 4 (DPP4) inhibitor Minocycline extended release (Emrosi; Ximino) – tetracycline antibiotic Minocycline topical (HY01) – tetracycline antibiotic MTC-896 – melanocortin receptor antagonist Nitric oxide (Enovid; FabiSpray; NORS-0791; NORS-1002; NORS-2791; NORS-4002; NORS-6491; NORS) – nitric oxide donor ORG-101 (acne vulgaris vaccine; ORI-001; ORI-A-ce001) – immunostimulant, vaccine Radezolid (RX-01667; Rx-01_667; RX-103; RX-1741) – oxazolidone antibiotic Research programme: antimicrobial therapies - NovaBiotics – cell membrane permeability enhancers Research programme: synthetic cannabinoid therapeutics - Claritas Pharmaceuticals – cannabinoids (cannabinoid receptor modulators) Research programme: therapeutic antibody fragments - Kuur Therapeutics – various actions Silver dihydrogen citrate (SDC; Axenohl) – antiseptic/antibacterial Tazarotene topical (DFD-03) – retinoid X receptor agonist
In July 2020, his series Die Hart premiered on Quibi on July 20 and had a strong first weekend. In March 2023, Roku and Hart's multi-platform comedy brand Laugh Out Loud debuted the series' second season on The Roku Channel. In addition to returning to his starring role, Hart executive produced the second season; Laugh Out Loud CEO and Hart's longtime business partner, Jeff Clanagan, served as a producer on the project. Hart signed a first look deal with Netflix in January 2021. He later played Arnold Drummond in the Diff'rent Strokes portion of the third edition of Live in Front of a Studio Audience. In 2022, Hart starred alongside Mark Wahlberg in the comedy film, Me Time. The film shows how Sonny (Hart) experiences a wild journey with his friend after finding a much-longed-for free weekend. In January 2024, Hart starred (alongside Úrsula Corberó from Money Heist and Vincent D'Onofrio) as a master thief in the Netflix comedy heist film Lift, directed by F. Gary Gray. A month later, he competed in season eleven of The Masked Singer as "Book". He purposely unmasked himself in the season eleven premiere as part of a prank on host Nick Cannon.
Sources: en.wikipedia.org
Amy M. Barrios is an American medicinal chemist working as a professor of Medicinal Chemistry and the Associate Dean for Postdoctoral Affairs for the University of Utah. Barrios' research lab focuses on developing probes to study protein tyrosine phosphatase (PTP) activity and regulation.
=== Dez Watkins === Dez Watkins (Martin Hancock) is a fixer working on behalf of Russian foreign intelligence to protect the interests of Tender. He is first seen approaching Rishi Ramdani and financial journalist Jim Dycker at a bar, warding off an apparent scammer. Rishi and Dycker invite Watkins for drinks and go back to Rishi's apartment to do drugs, where Dycker declares his plan to continue investigating Tender despite being fired by his publication. Watkins supplies them cocaine laced with fentanyl and raises the volume on Rishi's stereo before leaving, inciting a noise complaint that draws police to the apartment right as Dycker overdoses and dies from the poisoned drugs; Rishi is arrested while attempting to flee and is subsequently charged with manslaughter. Watkins later stops Whitney from attempting to disappear amidst escalating public scrutiny of Tender's fraud, having tracked him down to New York after Whitney's burner phone connected to airport WiFi. Watkins and Tender board member Ferdinand Schwarzwald (also a Russian asset) force Whitney to proceed with a takeover bid for Pierpoint, and warn Whitney that escape is not an option, with Watkins confirming that he murdered Dycker.
==== Economic Plan ==== During Bukele's second inauguration, he stated that his second term would focus on improving the Salvadoran economy with "bitter medicine" ("medicina amarga"). In July 2024, Bukele threatened to mass-arrest vendors, importers, and distributors who engaged in price gouging. Later that month, he announced the beginning of a six-phase Economic Plan ("Plan Económico"). Phase one, known as "Feeding" ("Alimentación"), involved the establishment of 30 food distribution centers and the removal of tariffs on certain agricultural imports for ten years. Phase two, known as "Technology" ("Tecnología"), involved the construction of data centers and technological parks in El Salvador. Bukele stated that his Economic Plan would create 4,000 jobs. Phase three, known as "Logistics" ("Logística"), involved the investment of US$1.6 billion into modernizing the ports of Acajutla and La Unión and the Turkish company Yılport Holdings operating the ports for 50 years.
== Reception == Decay received a weak but overall positive reception from the video games industry's critics. Writing for GameSpot, Doug Radcliffe argued that Decay was "impressive", praising the design of puzzles required players to work together, as well as the way in which the ranking system discouraged players from competing against each other. GameSpy's David Hodgson was more reserved in his views of the game; although describing it as "great fun", he noted that it could become "tedious, with one member waiting for minutes at a time, while the other scratches their head, then completes an objective". In addition, Hodgson felt that the more puzzle-orientated nature of Decay left the action elements "a little muted compared to Gordon's single player quest". Allgame described Decay as an "added bonus" for the PlayStation 2 version of Half-Life, but noted that as the game was designed for two players, it significantly suffered when a single player attempts to play it by switching between two characters, a point that both GameSpy and GameSpot agreed on. In his review for IGN, critic Doug Perry felt that Decay was "neat in its own limited way", but that it was more of a distraction from the main game, more "a complementary cup of vegetable soup than a piping hot main dish of New York steak". While The Electric Playground reviewer Steve Smith stated that the control scheme for the PlayStation 2 version of Half-Life "is about the best we have seen on the PS2 or any console", he concluded that although Decay was a "nice add-on", it was "no reason to buy this port".
2H-Site-specific Natural Isotope Fractionation-Nuclear Magnetic Resonance (2H-SNIF-NMR) is a type of NMR specialized in measuring the 2H concentration of organic molecules at natural abundances. The NMR spectra distinguish hydrogen atoms in different chemical environments (e.g. the order of carbon that hydrogen binds to, adjacent functional groups, and even geminal positions of methylene groups), making it a powerful tool for position-specific isotope analysis. The chemical shift (in frequency units) of 2H is 6.5x lower than that of 1H. Thus, it is hard to resolve 2H peaks. To provide enough resolution to separate 2H peaks, high-strength magnetic field instruments (~11.4T) are applied. Use of NMR to study hydrogen isotopes of natural products, was pioneered by Gerard Martin and his co-workers in the 1980s. For several decades it has been developed and expanded. The D/H NMR measurement is sometimes coupled with IR-MS measurement to create a referential standard. The sensitivity of SNIF-NMR is relatively low, typically requiring ~1 mmol of samples for each measurement. The precision with respect to isotope ratio is also poor compared to mass spectrometry. Even state-of-art instruments can only measure DHR with around 50~200‰ error depending on the compound. Therefore, so far technique can only distinguish the large D/H variations in preserved materials. In 2007, Philippe Lesot and his colleagues advanced this technique with a 2-dimensional NMR using chiral liquid crystals (CLC) instead of isotropic solvents to dissolve organic molecules.
Sources: en.wikipedia.org
== Acceptable levels of consumption == The acceptable daily intake (ADI) value for food additives, including aspartame, is defined as the "amount of a food additive, expressed on a body weight basis, that can be ingested daily over a lifetime without appreciable health risk". The Joint FAO/WHO Expert Committee on Food Additives (JECFA) and the European Commission's Scientific Committee on Food (later becoming EFSA) have determined this value is 40 mg/kg of body weight per day for aspartame, while the FDA has set its ADI for aspartame at 50 mg/kg per day – an amount equated to consuming 75 packets of commercial aspartame sweetener per day to be within a safe upper limit. The primary source for exposure to aspartame in the US is diet soft drinks, though it can be consumed in other products, such as pharmaceutical preparations, fruit drinks, and chewing gum among others in smaller quantities. A 12-US-fluid-ounce (350 ml; 12 imp fl oz) can of diet soda contains 0.18 grams (0.0063 oz) of aspartame, and, for a 75-kilogram (165 lb) adult, it takes approximately 21 cans of diet soda daily to consume the 3.7 grams (0.13 oz) of aspartame that would surpass the FDA's 50 mg/kg of body weight ADI of aspartame from diet soda alone. Studies of aspartame consumption in the US, Europe, Australia and other countries have shown that even high levels of intake are well below the ADI for safe consumption.
== History == In 2005, the Siuzdak Lab created an open-source tool named XCMS in the programming language R. Noticing the need for a more accessible, graphical data processing tool they created the cloud-based XCMS Online in 2012. The ability for users to stream data directly from instruments while being acquired was added in 2014. Also in that year a commercial version named XCMS Plus (owned by Mass Consortium Corporation) was released and, in 2015, SCIEX became a reseller. In 2017 it was shown that XCMS Online could be used in a systems biology workflow. One year later, in the absence of a publicly available alternative, a version of XCMS Online and METLIN-MRM was released with the ability to perform multiple reaction monitoring (MRM) and generate MRMs. In 2026, a new version of METLIN-MRM was introduced that enabled a more refined means of generating MRM isotope removal, in-source fragment removal and spline-fitting at multiple collision energies. The accuracy of uMRM was demonstrated on over 300 molecular standards as compared to traditional approaches.
=== Earth and agricultural sciences === In soil science, hydrology and agricultural sciences, water content has an important role for groundwater recharge, agriculture, and soil chemistry. Many recent scientific research efforts have aimed toward a predictive-understanding of water content over space and time. Observations have revealed generally that spatial variance in water content tends to increase as overall wetness increases in semiarid regions, to decrease as overall wetness increases in humid regions, and to peak under intermediate wetness conditions in temperate regions . There are four standard water contents that are routinely measured and used, which are described in the following table:
A research study that follows over time groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke and those who do not smoke) and compares them for a particular outcome. (NCI) Clinical trial protocol
Homozygous or compound heterozygous mutations are therefore likely subject to differential regulation depending on whether they are double missense, double truncating or mixed missense/truncating mutations. The homozygous Mybpc3-targeted knock-in mice, which genetically mimic the situation of severe neonatal cardiomyopathy are born without phenotype and soon after birth develop systolic dysfunction followed by (compensatory) cardiac hypertrophy. The human c.772G>A transition results in low levels of three different mutant Mybpc3 mRNAs and cMyBP-Cs in homozygous mice, suggesting a combination of haploinsufficiency and polypeptide poisoning as disease mechanism in the homozygous state. In addition, the combination of external stress (such as neurohumoral stress or aging) and Mybpc3 mutations have been shown to impair the UPS in mice, and proteasomal activities were also depressed in patients with hypertrophic cardiomyopathy or dilated cardiomyopathy. Skinned trabeculae or cardiac myocytes obtained from human patients carrying a MYBPC3 mutation or from heterozygous and homozygous Mybpc3-targeted knock-in mice exhibited higher myofilament Ca2+ sensitivity than controls. Disease-modeling by engineered heart tissue (EHT) technology with cardiac cells from heterozygous or homozygous Mybpc3-targeted knock-in mice reproduced observations made in human and mouse studies displaying abbreviated contractions, greater sensitivity to external Ca2+ and smaller inotropic responses to various drugs (isoprenaline, EMD 57033 and verapamil) compared to wild-type control EHTs.
Sources: en.wikipedia.org
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.
The single bridge between two cysteine residues holds the chain in a folded loop that influences its shape and its behavior in solution. Loss of the bridge through reduction or oxidation shifts chromatographic retention and is tracked during stability work.
It is a defined 28-residue sequence derived from a larger precursor, whereas many other thymic preparations are mixtures of several polypeptides. Its acetylated amino terminus and single disulfide bridge distinguish it chemically from unrelated thymic extracts.
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.